We play a key role in the distribution of a wide variety of IP Efavirenz Tablets. It is employed to treat HIV-1 infection. It is a member of the group of drugs known as non-nucleoside reverse transcriptase inhibitors. This range is utilized as a part of a thorough HIV-1 infection treatment plan in conjunction with other antiretroviral drugs. Patients who have a history of allergy or hypersensitivity to any of the medication's ingredients shouldn't take efavirenz tablets IP. For the treatment of HIV-1 infection, provided range is an efficient drug. Patients should adhere to their doctor's instructions and communicate any adverse effects or worries they may have with them.
Specification
Medicine Type |
Allopathic |
Manufacturer |
Cipla Ltd |
Packaging Type |
Box |
Packaging Size |
30 Tablets |
Dose/Strength |
600 mg |
Dosage Form |
Tablet |
Composition |
Efavirenz |